WCN26-3406 Impact of CYP3A5 gene polymorphism on tacrolimus pharmacokinetics in kidney transplant patients: evidence in Kazakh population

Read full text Summarise with VIRAT
Authors: Bolatbek Baimakhanov, Islam K. Madadov
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

With the improvement of donor selection, surgical technique and rational immunosuppressive treatment rates of short-term graft survival great increased. 1 –year graft survival from deceased donor is 95% whereas from living related donor is 98%. In Kazakhstan 1-year graft survival from living related donor is 91%. Despite these high indicators of 1-year graft survival, 5-year graft survival rates remain to be low. For example, in USA 5-year graft survival from decease donor is up to 80%, whereas from living donor is form 82 to 90 %, respectively.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Pharmacogenetics and Drug Metabolism Transplantation: Methods and Outcomes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105463–105463
Publication date
25 March 2026
Language
EN